lifestyle.sourcefed.com

Author: https://immatics.com/

Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting

April 21, 2026
PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma

April 17, 2026
Immatics Announces Full Year 2025 Financial Results and Business Update

March 5, 2026